Navigation Links
Regado Biosciences Permanently Halts REGULATE-PCI Clinical Trial
Date:8/25/2014

cogin, an anticoagulant aptamer specifically targeting coagulation Factor IXa, and its complementary oligonucleotide active control agent, anivamersen. Regado's actively controllable product candidates have the potential to improve patient outcomes and enhance the patient experience, provide direct therapeutic control to physicians and reduce overall treatment costs. More information can be found at www.regadobio.com. For more information on REGULATE-PCI, please visit: http://www.clinicaltrials.gov/ct2/show/NCT01848106

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements reflect management's current expectations, as of the date of this press release, and involve certain risks and uncertainties. Forward-looking statements include statements herein with respect to the progress of the REGULATE-PCI trial, the expected timing and outcome of our analysis of the unblended REGULATE-PCI database, the prospects for the continued development and any regulatory approval of Revolixys™ Kit and the successful commercialization of Revolixys™ Kit, if approved. The Company's actual results could differ materially from those anticipated in these forward-looking statements as a result of various factors. Factors that could cause future results to materially differ from those projected in forward-looking statements include the outcome of our database analysis, our determination of the safety and/or efficacy of Revolixys™ Kit as well as the "Risk Factors" described in the Company's Annual Report on Form 10-K filed with the Securities and Exchange Commission on March 12, 2014, and in the Company's other periodic filings with the SEC. All forward-looking statements are expressly qualified in their entirety by this cautionary
'/>"/>

SOURCE Regado Biosciences, Inc.
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Regado Biosciences to Provide Second Quarter 2014 Financial Results and Corporate Highlights
2. Attention Regado Biosciences, Inc. Investors: Regado Misled Investors According to a Recently Filed Class Action
3. Regado Biosciences, Inc. Adds World-Class Interventional Cardiologist and Researcher to Medical Advisory Board
4. Regado Biosciences, Inc. Adds Global Pharmaceutical Business Veteran to Board of Directors
5. Regado Biosciences, Inc. Announces Third Quarter 2013 Results
6. Regado Biosciences, Inc. Announces Closing of Initial Public Offering
7. Regado Biosciences, Inc. Announces Pricing of Initial Public Offering
8. Regado Biosciences, Inc. to Present at the Oppenheimer 23rd Annual Healthcare Conference in New York, NY
9. Regado Biosciences, Inc. to Present at the UBS Global Life Sciences Conference 2012 in New York, NY
10. Regado Biosciences, Inc. to Present at the Canaccord Genuity 32nd Annual Growth Conference in Boston, MA
11. Regado Biosciences, Inc. to Present at the 2012 Wedbush PacGrow Life Sciences Conference in New York, NY
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... and VANCOUVER , July 2, ... (TSX-V: EPI) announced today that its common shares have been ... ("NASDAQ") under the symbol "EPIX". ESSA will begin ... retain its listing on the TSX Venture Exchange under the ... of the common shares on the NASDAQ, each of the ...
(Date:7/2/2015)... 2015 Releases of the genetically ... aegypti , , reduced the dengue mosquito population ... by 95%, well below the modelled threshold for ... The journal PLOS Neglected Tropical Diseases published ... engineered mosquitoes. The results showed that in Juazeiro city, ...
(Date:7/2/2015)...   EVO Aesthetic Center and Wellness Spa ... aesthetics in Lakeway, Texas and ... Astanza Duality laser. The medical spa is focused on ... and laser procedures. Their addition of the Astanza Duality ... to their tattoo regret. "The large number ...
Breaking Medicine Technology:ESSA Pharma Inc. to Commence Trading on the NASDAQ Capital Market 2ESSA Pharma Inc. to Commence Trading on the NASDAQ Capital Market 3ESSA Pharma Inc. to Commence Trading on the NASDAQ Capital Market 4Oxitec Mosquito Works to Control Aedes aegypti in Dengue Hotspot 2Oxitec Mosquito Works to Control Aedes aegypti in Dengue Hotspot 3EVO Offers Advanced Laser Tattoo Removal With Astanza Duality In Lakeway, TX 2
... Md., Oct. 15 EntreMed, Inc. (Nasdaq: ... therapeutics for the treatment of cancer, today announced ... NASDAQ Stock Market indicating that it has regained ... of Listed Securities ("MVLS") requirement for continued listing ...
... Cellectis (Alternext: ALCLS), the French genome engineering specialist, today ... June 30, 2010: revenues increased 25% over H1 2009, ... with euro 38 million in cash reserves. ... a number of important new agreements (with BASF Plant ...
Cached Medicine Technology:EntreMed Receives Notice of NASDAQ Compliance 2Cellectis Publishes Its Financial Statement for the First Half of 2010 2Cellectis Publishes Its Financial Statement for the First Half of 2010 3
(Date:7/2/2015)... ... July 02, 2015 , ... The American Association of Poison ... Stop Overdose Stat (S.O.S.) Act of 2015 on June 23, 2015. Together with ... to decrease drug overdose – especially of heroin and opioid medication – by ...
(Date:7/2/2015)... ... , ... In 2012, Patrick Achebe realized that the gift of poetry was fully in him, ... his first poem, and three years later he was publishing an entire book of poetry. ... the world. "I have always believed that the best way to lift yourself up, is ...
(Date:7/2/2015)... ... July 02, 2015 , ... Global leader and compression innovator, ... socks designed for men. , For style that’s quick on its feet, men ... This is great news for men everywhere because a simple change in socks can ...
(Date:7/2/2015)... , ... July 02, 2015 , ... ... Emerging Healthcare Delivery Coalition met for the late June Web-based session, the speakers ... new reimbursement schemes and managing high-risk patients through coordinated care. , During the ...
(Date:7/2/2015)... ... July 02, 2015 , ... Facial plastic surgery is about ... is an art and science that goes into successful facial reconstruction and contouring. ... features and lives of more than 2,500 satisfied facelift and neck lift patients ...
Breaking Medicine News(10 mins):Health News:AAPCC Supports the Stop Overdose Stat Act of 2015 2Health News:AAPCC Supports the Stop Overdose Stat Act of 2015 3Health News:Patrick Achebe Releases Debut Book, Whispering Waves: Poems for Everyday Grace 2Health News:SIGVARIS Kicks Up Its Style for Men with the Launch of MIDTOWN MICROFIBER in a Dark Navy Stripe Pattern 2Health News:SIGVARIS Kicks Up Its Style for Men with the Launch of MIDTOWN MICROFIBER in a Dark Navy Stripe Pattern 3Health News:ACO Coalition Discusses the Future of Medicare Payments and the Benefits of Providing More Care 2Health News:ACO Coalition Discusses the Future of Medicare Payments and the Benefits of Providing More Care 3Health News:ACO Coalition Discusses the Future of Medicare Payments and the Benefits of Providing More Care 4Health News:Dr. Kevin Sadati Featured in July Issue of Popular National Magazines 2Health News:Dr. Kevin Sadati Featured in July Issue of Popular National Magazines 3
... women scheduled for gynecologic surgery to address noncancerous symptoms said ... about the effects of the procedure on their sex lives. ... be sterilized did express concern in this study that they ... though that surgery does not affect hormone levels. Among ...
... ... and technology with OPS, a new one-day event embracing the entire online advertising community. ... on September 30, 2010 in New York City. Sales drives revenue, but operations determines ... (PRWEB) ...
... all SSRIs, researchers say , MONDAY, April 12 (HealthDay ... antidepressants in raising a kid,s risk of suicidal thoughts, ... the U.S. Food and Drug Administration,s decision in 2004 ... for an increased suicidality risk in children and adolescents ...
... lesions in the process of intestinal type gastric cancer. ... lesions is still unclear, a few studies have investigated the ... intestinal metaplasia, but all of them are limited by their ... published on April 14, 2010 in the World Journal ...
... at the University of Liverpool have discovered that dangerous strains ... infected with HIV in Africa. Their research has ... can cause severe disease by invading cells in the ... them to evolve into more dangerous, multi-drug resistant strains over ...
... ... , ... New Jersey (PRWEB) April 12, 2010 -- Physicians, nurse practitioners, and physician assistants in ... are invited to attend “Recognizing and Treating Multiple Sclerosis in the Primary Care Setting,” ...
Cached Medicine News:Health News:Most women facing gynecologic surgery don't worry about its effects on sex 2Health News:Most women facing gynecologic surgery don't worry about its effects on sex 3Health News:Most women facing gynecologic surgery don't worry about its effects on sex 4Health News:AdMonsters Announces the Launch of OPS, to be Held on September 30, 2010 in New York 2Health News:AdMonsters Announces the Launch of OPS, to be Held on September 30, 2010 in New York 3Health News:Kids' Suicide Risk Same for All Antidepressants 2Health News:Kids' Suicide Risk Same for All Antidepressants 3Health News:Prevalence of HIV in Africa is leading to new strains of Salmonella, say scientists 2Health News:Free CME/CE Lecture and Workshop on Multiple Sclerosis: Boise, ID 2
Escherichia coli - For the qualitative detection of Escherichia coli 0157 and 0157:H7 in food products Accessories BinaxNOW EH E.coli 0157 & 0157:H7 Control Swab Pack (510-000) ...
Escherichia coli - For the qualitative detection of Escherichia coli 0157 and 0157:H7 in food products. Accessories BinaxNOW EH E.coli 0157 & 0157:H7 Control Swab Pack (510-000), BinaxNow E.coli...
For the qualitative detection of cardiac troponin I (cTnl) in human whole blood and serum specimens...
For the qualitative detection of antibodies to Treponema pallidum in human serum, plasma and whole blood specimens...
Medicine Products: